Artículo
Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study
Autor/es | Machado, Carmen
Ríos-Villegas, María José Gálvez-Acebal, Juan Domínguez Castellano, Angel Fernández-Cuenca, Felipe Palomo, Virginia Muniain Ezcurra, Miguel Angel Rodríguez-Baño, Jesús |
Departamento | Universidad de Sevilla. Departamento de Medicina |
Fecha de publicación | 2012 |
Fecha de depósito | 2016-04-26 |
Publicado en |
|
Resumen | Background: To describe the long term outcome of patients who interrupted highly active antiretroviral therapy
(HAART) once, identify the variables associated with earlier need to re-start HAART, and the response when ... Background: To describe the long term outcome of patients who interrupted highly active antiretroviral therapy (HAART) once, identify the variables associated with earlier need to re-start HAART, and the response when therapy was resumed. A retrospective observational cohort of 66 adult patients with HIV-1 infection who interrupted HAART with a CD4+cell count ≥350 cells/μL and undetectable viral load (VL) was performed. The pre-established CD4+ cell count for restarting therapy was 300cells/μL. Cox regression was used to analyse the variables associated with earlier HAART reinitiation. Results: The median follow-up was 209 weeks (range, 64–395). Rates of HIV-related or possible HIV-related events were 0.37 (one case of acute retroviral syndrome) and 1.49 per 100 patient-years, respectively. Two patients died after re-starting therapy and having reached undetectable VL. Three patients suffered a sexually transmitted disease while off therapy. Fifty patients (76%) resumed therapy after a median of 97 weeks (range, 17–267). Age, a nadir of CD4+ <250 cells/μL, and a mean VL during interruption of >10,000 copies/ml were independent predictors for earlier re-start. The intention-to-treat success rate of the first HAART resumed regimen was 85.4%. There were no differences by regimen used, nor between regimens that were the same as or different from the one that had been interrupted. Conclusions: Our data suggest highly active antiretroviral therapy may be interrupted in selected patients because in these patients, when the HAART is restarted, the viral and clinical response may be achieved. |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
20424583.pdf | 557.3Kb | [PDF] | Ver/ | |